Thoth's Triad
Triple Wisdom of Metabolic Mastery
Retatrutide · GLP-1/GIP/Glucagon Triple Agonist
For research & educational purposes only. ≥99.97% purity. Manufactured by Bachem, Switzerland.
Retatrutide is a first-in-class triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Named Thoth’s Triad after the ibis-headed god of wisdom who united three realms of knowledge.
Retatrutide achieves superior metabolic effects through triple-agonism: GLP-1 for appetite regulation and insulin secretion, GIP for enhanced incretin effect, and glucagon for increased energy expenditure and hepatic fat mobilization.
Manufactured by Bachem AG under cGMP/ICH Q7 conditions with ≥99.97% HPLC purity and endotoxin-free certification.
Key Benefits
Triple Receptor Agonism
Simultaneously activates GLP-1, GIP, and glucagon receptors for synergistic metabolic control.
Appetite Regulation
Centrally modulates satiety signaling for sustained appetite reduction and caloric control.
Energy Expenditure
Glucagon receptor activation increases hepatic fat mobilization and basal metabolic rate.
Insulin Sensitisation
Improves pancreatic beta-cell function and peripheral glucose uptake efficiency.
This product is intended for in-vitro research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.